Literature DB >> 8798239

Increased levels of lipid peroxidation products malondialdehyde and 4-hydroxynonenal after perinatal hypoxia.

H Schmidt1, T Grune, R Müller, W G Siems, R R Wauer.   

Abstract

For quantitative evaluation of lipid peroxidation after perinatal hypoxia in umbilical arterial cord blood samples from 109 healthy, acidotic, and asphyctic neonates with a gestational age ranging from 26 to 41 wk, the levels of aldehydic lipid peroxidation products malondialdehyde (MDA) and 4-hydroxynon-2-enal (HNE) were measured. Furthermore, the concentrations of oxidized and reduced glutathione (GSSH and GSH) and the purine compounds hypoxanthine and uric acid were determined. With increasing gestational age MDA and HNE levels increased. Furthermore, an increased level of GSH was also found. After perinatal hypoxia the concentrations of MDA and HNE rose distinctly (p < 0.001), reflecting sensitively the extent of in vivo lipid peroxidation. HNE is proposed to be a new parameter for quantitative evaluation of posthypoxic cellular damage in the perinatal period. HNE is a more specific parameter for estimation of lipid peroxidation processes in comparison with MDA. Additionally, HNE is cytotoxic and mutagenic at nanomolar concentrations. The increased levels of both MDA and HNE were accompanied by a strong decrease of GSH concentrations (p < 0.001), indicating the rapid consumption of GSH via a glutathione peroxidase reaction but additionally the high reactivity of HNE with sulfhydryl groups. During oxygen deficiency, increased levels of hypoxanthine (p < 0.01) and uric acid (p < 0.05) were due to the accelerated degradation of purine nucleotides. The rate of purine degradation including xanthine oxidase reactions characterizes the extent of an important radical source during oxygen deficiency, contributing to peroxidation of polyunsaturated fatty acids and the formation of peroxidation of polyunsaturated fatty acids and the formation of secondary aldehydic lipid peroxidation products.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8798239     DOI: 10.1203/00006450-199607000-00003

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  15 in total

1.  Neuroprotective effects of TRPA1 channels in the cerebral endothelium following ischemic stroke.

Authors:  Paulo Wagner Pires; Scott Earley
Journal:  Elife       Date:  2018-09-21       Impact factor: 8.140

Review 2.  4-Hydroxy-nonenal-A Bioactive Lipid Peroxidation Product.

Authors:  Rudolf J Schaur; Werner Siems; Nikolaus Bresgen; Peter M Eckl
Journal:  Biomolecules       Date:  2015-09-30

Review 3.  The role of oxidative stress in Parkinson's disease.

Authors:  Vera Dias; Eunsung Junn; M Maral Mouradian
Journal:  J Parkinsons Dis       Date:  2013       Impact factor: 5.568

4.  Plumbagin, a vitamin K3 analogue ameliorate malaria pathogenesis by inhibiting oxidative stress and inflammation.

Authors:  Amit Chand Gupta; Shilpa Mohanty; Archana Saxena; Anil Kumar Maurya; Dnyaneshwar U Bawankule
Journal:  Inflammopharmacology       Date:  2018-03-22       Impact factor: 4.473

5.  Raised concentrations of aldehyde lipid peroxidation products in premature infants with chronic lung disease.

Authors:  T Ogihara; K Hirano; T Morinobu; H S Kim; M Hiroi; H Ogihara; H Tamai
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-01       Impact factor: 5.747

6.  Effect of mode of birth on purine and malondialdehyde in umbilical arterial plasma in normal term newborns.

Authors:  T C Calderon; W Wu; R A Rawson; E P Sakala; L C Sowers; D S Boskovic; D M Angeles
Journal:  J Perinatol       Date:  2008-03-27       Impact factor: 2.521

Review 7.  Oxidative risk for atherothrombotic cardiovascular disease.

Authors:  Jane A Leopold; Joseph Loscalzo
Journal:  Free Radic Biol Med       Date:  2009-09-12       Impact factor: 7.376

Review 8.  Free radicals and neonatal encephalopathy: mechanisms of injury, biomarkers, and antioxidant treatment perspectives.

Authors:  Silvia Martini; Topun Austin; Arianna Aceti; Giacomo Faldella; Luigi Corvaglia
Journal:  Pediatr Res       Date:  2019-10-26       Impact factor: 3.756

9.  Transfer of 4-hydroxynonenal from parasitized to non-parasitized erythrocytes in rosettes. Proposed role in severe malaria anemia.

Authors:  Sophie Uyoga; Oleksii A Skorokhod; Michael Opiyo; Emily N Orori; Thomas N Williams; Paolo Arese; Evelin Schwarzer
Journal:  Br J Haematol       Date:  2012-01-20       Impact factor: 6.998

10.  Antenatal melatonin as an antioxidant in human pregnancies complicated by fetal growth restriction--a phase I pilot clinical trial: study protocol.

Authors:  Nicole O Alers; Graham Jenkin; Suzanne L Miller; Euan M Wallace
Journal:  BMJ Open       Date:  2013-12-23       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.